Correlation Between Takeda Pharmaceutical and Rubicon Organics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Rubicon Organics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Rubicon Organics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Rubicon Organics, you can compare the effects of market volatilities on Takeda Pharmaceutical and Rubicon Organics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Rubicon Organics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Rubicon Organics.

Diversification Opportunities for Takeda Pharmaceutical and Rubicon Organics

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Takeda and Rubicon is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Rubicon Organics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rubicon Organics and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Rubicon Organics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rubicon Organics has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Rubicon Organics go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Rubicon Organics

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.21 times more return on investment than Rubicon Organics. However, Takeda Pharmaceutical Co is 4.87 times less risky than Rubicon Organics. It trades about 0.04 of its potential returns per unit of risk. Rubicon Organics is currently generating about -0.01 per unit of risk. If you would invest  1,281  in Takeda Pharmaceutical Co on August 26, 2024 and sell it today you would earn a total of  57.00  from holding Takeda Pharmaceutical Co or generate 4.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Takeda Pharmaceutical Co  vs.  Rubicon Organics

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Rubicon Organics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rubicon Organics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's forward-looking indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Takeda Pharmaceutical and Rubicon Organics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and Rubicon Organics

The main advantage of trading using opposite Takeda Pharmaceutical and Rubicon Organics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Rubicon Organics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rubicon Organics will offset losses from the drop in Rubicon Organics' long position.
The idea behind Takeda Pharmaceutical Co and Rubicon Organics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.